293. Starting Verzenio? Debbie’s Experience May Help You Prepare
Published: April 15, 2026
Duration: 33:56
Love the podcast? Send us a text!
Every breast cancer treatment plan is highly personalized, and understanding potential side effects can help patients feel more prepared, informed, and empowered throughout care.
In this episode of Breast Cancer Conversations, Laura speaks with Debbie Ciak, a breast cancer survivor diagnosed with Stage 2B ER/PR-positive, HER2-negative breast cancer with lymph node involvement.
Due to features associated with a higher risk of recurrence, Debbie’s care team recommended treatment with Verzenio (abemaciclib), a CDK4/6 inhibitor commonly prescribed alongside endocrine therapy for certain HR+, HER2- br...